Pulished Date October, 2018
ID: 4407
Share on
Share on

Wearable Cardioverter Defibrillator Market By Conditions (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias), By End User (Hospitals, Home Care Settings, Cardiology Clinics), By Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2024

Pulished: October, 2018
ID: 4407
Pages: 178

Wearable cardioverter defibrillator is a gadget that is non-invasive it is utilized to prevent sudden heart attack. It has two parts: A light weight jacket which is worn under regular clothes and a small mobile unit which includes recorder and generator. Sudden heart attack occurs when the heart's electrical system malfunctions. It directs the heart to relax and contract. Those conditions where there is abnormal rhythm in the ventricles of the heart is known as Ventricular Fibrillation. When VF occurs, a WCD sends an electrical current to the heart that is used to revive a normal heart rhythm. Defibrillators are used for the treatment of life-threatening ventricular fibrillation, heart dysrhythmias, and ventricular tachycardia.

Wearable Cardioverter Defibrillator Market Forecast Report ( 2018- 2023):

The Global Wearable Cardioverter Defibrillator Market size was around USD XX billion in 2018. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2023.

Wearable Cardioverter Defibrillator Market Growth:

Rising prevalence of diseases, increasing geriatric population, growing number of training and awareness among the population base and, technological advancements are the primary drivers of the market.On the other hand, factors like problems related to the use of wearable cardioverter defibrillator devices, inadequate knowledge regarding sudden cardiac arrest, and the wearable cardioverter defibrillator does not monitor atrial arrhythmias thus this hinders the growth of the market.

Wearable Cardioverter Defibrillator Market Segmentation:

Wearable Cardioverter Defibrillator Market segmentation by Conditions and by End User. By Conditions it is segmented into Peripartum Cardiomyopathy, Congenital Heart Disease, and Inherited Arrhythmias. By End User the market is segmented into Hospitals, Home Care Settings, and Cardiology Clinics.

Wearable Cardioverter Defibrillator Market geographical segmentation by Europe, Latin America, North America, Asia Pacific, and Middle East and Africa. North America commands the largest market share of the overall industry and is likely to keep ruling the business sector due to growing incidence of diseases, enhancement in healthcare industry and extended growth. US and Canada contribute highest to the overall market in the region because of the awareness regarding the sudden cardiac arrest and defibrillators. Europe is the second largest market. The Market is majorly driven by rise in demand from developing economies in the Asia Pacific and Middle East regions, where more workstations and business environments are introducing advancement in defibrillators. It is projected to benefit the defibrillators market in the aforementioned forecast period.

Wearable Cardioverter Defibrillator Market Key players:

The major Wearable Cardioverter Defibrillator Market leaders are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan)

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Conditions                  

                                5.1.1 Introduction           

                                5.1.2 Peripartum Cardiomyopathy           

                                5.1.3 Congenital Heart Disease  

                                5.1.4 Inherited Arrhythmias       

                                5.1.5  Y-o-Y Growth Analysis, By Conditions         

                                5.1.6  Market Attractiveness Analysis, By Conditions       

                                5.1.7  Market Share Analysis, By Conditions        

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Home Care Settings            

                                5.2.4 Cardiology Clinics  

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Conditions

                                                6.1.3.3 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Conditions

                                                6.1.4.3 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Conditions

                                                6.1.5.3 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 ZOLL Medical Corporation                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Medtronic PLC (Ireland)                        

                8.3 St. Jude Medical                       

                8.4 Boston Scientific Corporation (U.S.)                 

                8.5 BIOTRONIK SE & Co. KG (Germany)                 

                8.6 LivaNova PLC (U.K.)                

                8.7 Koninklijke Philips N.V. (Netherlands)                            

                8.8 Cardiac Science Corporation (U.S.)                   

                8.9 Physio-Control                          

                8.10 Nihon Kohden Corporation (Japan)                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Conditions and by End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Wearable Cardioverter Defibrillator Market By Region, From 2019-2024 ( USD Million )
  2. Global Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  3. Global Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  4. Global Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  5. Global Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  6. Global Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  7. Global Hospital Market By Region, From 2019-2024 ( USD Million )
  8. Global Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  9. Global Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  10. North America Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  11. North America Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  12. North America Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  13. North America Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  14. North America Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  15. North America Hospital Market By Region, From 2019-2024 ( USD Million )
  16. North America Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  17. North America Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  18. United States Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  19. United States Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  20. Canada Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  21. Canada Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  22. Europe Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  23. Europe Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  24. Europe Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  25. Europe Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  26. Europe Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  27. Europe Hospital Market By Region, From 2019-2024 ( USD Million )
  28. Europe Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  29. Europe Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  30. U.K. Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  31. U.K. Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  32. Germany Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  33. Germany Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  34. France Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  35. France Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  36. Italy Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  37. Italy Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  38. Spain Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  39. Spain Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  40. Asia Pacific Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  41. Asia Pacific Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  42. Asia Pacific Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  43. Asia Pacific Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  44. Asia Pacific Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  45. Asia Pacific Hospital Market By Region, From 2019-2024 ( USD Million )
  46. Asia Pacific Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  47. Asia Pacific Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  48. Japan Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  49. Japan Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  50. China Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  51. China Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  52. India Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  53. India Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  54. Australia Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  55. Australia Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  56. South Korea Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  57. South Korea Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  58. Latin America Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  59. Latin America Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  60. Latin America Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  61. Latin America Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  62. Latin America Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  63. Latin America Hospital Market By Region, From 2019-2024 ( USD Million )
  64. Latin America Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  65. Latin America Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  66. Brazil Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  67. Brazil Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  68. Argentina Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  69. Argentina Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  70. Mexico Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  71. Mexico Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  72. Rest of Latin America Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  73. Rest of Latin America Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  74. Middle East and Africa Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  75. Middle East and Africa Peripartum Cardiomyopathy Market By Region, From 2019-2024 ( USD Million )
  76. Middle East and Africa Congenital Heart Disease Market By Region, From 2019-2024 ( USD Million )
  77. Middle East and Africa Inherited Arrhythmias Market By Region, From 2019-2024 ( USD Million )
  78. Middle East and Africa Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  79. Middle East and Africa Hospital Market By Region, From 2019-2024 ( USD Million )
  80. Middle East and Africa Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  81. Middle East and Africa Cardiology Clinics Market By Region, From 2019-2024 ( USD Million )
  82. Middle East Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  83. Middle East Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )
  84. Africa Wearable Cardioverter Defibrillator Market By Conditions, From 2019-2024 ( USD Million )
  85. Africa Wearable Cardioverter Defibrillator Market By End User, From 2019-2024 ( USD Million )

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients